NOVERA RETATRUTIDE: A NEW APPROACH FOR BODY MANAGEMENT?

Recent clinical information suggests that Novera Retatrutide, a combined-action treatment from Novo Nordisk, could represent a meaningful advance in weight management. Beyond many existing options, Retatrutide affects both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP), potentially